Skip to content

Author

I. Meattini

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Reirradiation With Proton Therapy Using Hypofractionated Schedules: A Systematic Review of the Literature

Evidence supporting the use of hypofractionated PT re-RT remains limited but encouraging, and identifying predictors of toxicity and treatment response is essential to guide future research and to establish this approach as a viable option for selected patients.

D. Alterio, V. Pierini, S. Volpe et al. · 0 citations
Open access Sep 2026

Prognostic value of hormone receptor expression in patients with HR+/HER2− advanced BC treated with first-line ET+CDK4/6i: results from the multicentre observational, real-world PALMARES-2 study

Effectiveness of first-line ET plus CDK4/6i in patients with HR+/HER2− aBC worsens progressively with decreasing ERα expression, and PgR expression adds further prognostic discrimination, with low ERα and PgR expression identifying a subgroup of patients with particularly poor outcomes.

F. Ligorio, L. Provenzano, R. Caputo et al. · 0 citations
Review Open access Sep 2026

Safety of combining radiation therapy and antibody-drug conjugates in patients with breast cancer: a systematic review and meta-analysis.

BACKGROUND AND PURPOSE The treatment landscape for breast cancer has undergone significant advancements in the recent years, with the introduction of several new anticancer agents, especially those belonging to the antibody-drug conjugates (ADCs) class. However, there exists a lack of comprehensive evidence regarding t...

L. Visani, C. Becherini, M. Kubeczko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.